Literature DB >> 18362811

How much are Americans willing to pay for a quality-adjusted life year?

Milton C Weinstein.   

Abstract

Mesh：

Year:  2008        PMID： 18362811     DOI： 10.1097/MLR.0b013e31816a7144

Source DB:  PubMed          Journal:  Med Care        ISSN： 0025-7079            Impact factor:   2.983


× No keyword cloud information.
  44 in total

1.  The price of tenofovir-emtricitabine undermines the cost-effectiveness and advancement of pre-exposure prophylaxis.

Authors:  Samuel B Keller; Davey M Smith
Journal:  AIDS       Date:  2011-11-28       Impact factor: 4.177

2.  The value of a QALY: individual willingness to pay for health gains under risk.

Authors:  Ana Bobinac; Job van Exel; Frans F H Rutten; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2014-01       Impact factor: 4.981

3.  Cost-effectiveness analysis of smoking cessation interventions using cell phones in a low-income population.

Authors:  Allan T Daly; Ashish A Deshmukh; Damon J Vidrine; Alexander V Prokhorov; Summer G Frank; Patricia D Tahay; Maggie E Houchen; Scott B Cantor
Journal:  Tob Control       Date:  2018-06-09       Impact factor: 7.552

4.  Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists.

Authors:  Scott B Cantor; Ashish A Deshmukh; Nancy Stancic Luca; Graciela M Nogueras-González; Tanya Rajan; Alexander V Prokhorov
Journal:  Addict Behav       Date:  2015-01-14       Impact factor: 3.913

5.  Measuring the end-of-life premium in cancer using individual ex ante willingness to pay.

Authors:  S Olofsson; U-G Gerdtham; L Hultkrantz; U Persson
Journal:  Eur J Health Econ       Date:  2017-08-12

6.  Overtreatment and Cost-Effectiveness of the See-and-Treat Strategy for Managing Cervical Precancer.

Authors:  Van T Nghiem; Kalatu R Davies; J Robert Beck; Michele Follen; Scott B Cantor
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02-29       Impact factor: 4.254

7.  Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis.

Authors:  T Enden; S Resch; C White; H S Wik; N E Kløw; P M Sandset
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

8.  Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.

Authors:  Tracy A Lieu; G Thomas Ray; Ismael R Ortega-Sanchez; Ken Kleinman; Donna Rusinak; Lisa A Prosser
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 9.  Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.

Authors:  Sanjib Saha; Ulf-G Gerdtham; Pia Johansson
Journal:  Int J Environ Res Public Health       Date:  2010-08-09       Impact factor: 3.390

10.  Economic Decision Model Suggests Total Shoulder Arthroplasty is Superior to Hemiarthroplasty in Young Patients with End-stage Shoulder Arthritis.

Authors:  Suneel B Bhat; Mark Lazarus; Charles Getz; Gerald R Williams; Surena Namdari
Journal:  Clin Orthop Relat Res       Date:  2016-07-25       Impact factor: 4.176
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.